Federal Register / Vol. 77, No. 63 / Monday, April 2, 2012 / Notices 19677 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6100 

Executive Boulevard, Rockville, MD 20852, 

(Telephone Conference Call). 

Contact Person: Marita R. Hopmann, Ph.D., 

Scientific Review Officer, Division of 

Scientific Review, Eunice Kennedy Shriver 

National Institute of Child Health and 

Human Development, NIH, 6100 Executive 

Blvd. Room 5B01, Bethesda, MD 20892, 301– 

435–6911, hopmannm@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.864, Population Research; 

93.865, Research for Mothers and Children; 

93.929, Center for Medical Rehabilitation 

Research; 93.209, Contraception and 

Infertility Loan Repayment Program, National 

Institutes of Health, HHS) 

Dated: March 27, 2012. 

Jennifer S. Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2012–7834 Filed 3–30–12; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Diabetes and 

Digestive and Kidney Diseases; Notice 

of Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Diabetes and Digestive and Kidney Diseases 

Special Emphasis Panel, Epidemiology of 

Diabetes. 

Date: April 19, 2012. 

Time: 9 a.m. to 11 a.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, Two 

Democracy Plaza, 6707 Democracy 

Boulevard, Bethesda, MD 20892 (Telephone 

Conference Call). 

Contact Person: Thomas A. Tatham, Ph.D., 

Scientific Review Officer, Review Branch, 

DEA, NIDDK, National Institutes of Health, 

Room 760, 6707 Democracy Boulevard, 

Bethesda, MD 20892–5452, (301) 594–3993, 

tathamt@mail.nih.gov. 

Name of Committee: National Institute of 

Diabetes and Digestive and Kidney Diseases 

Special Emphasis Panel, PO1 Applications. 

Date: June 18, 2012. 

Time: 2 p.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, Two 

Democracy Plaza, 6707 Democracy 

Boulevard, Bethesda, MD 20892 (Telephone 

Conference Call). 

Contact Person: D. G. PATEL, Ph.D., 

Scientific Review Officer, Review Branch, 

DEA, NIDDK, National Institutes of Health, 

Room 756, 6707 Democracy Boulevard, 

Bethesda, MD 20892–5452, (301) 594–7682, 

pateldg@niddk.nih.gov. 

Name of Committee: National Institute of 

Diabetes and Digestive and Kidney Diseases 

Special Emphasis Panel, DP3 Reviews. 

Date: June 28–29, 2012. 

Time: 5 p.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Bethesda Marriott Suites, 6711 

Democracy Boulevard, Bethesda, MD 20817. 

Contact Person: D. G. PATEL, Ph.D., 

Scientific Review Officer, Review Branch, 

DEA, NIDDK, National Institutes of Health, 

Room 756, 6707 Democracy Boulevard, 

Bethesda, MD 20892–5452, (301) 594–7682, 

pateldg@niddk.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.847, Diabetes, 

Endocrinology and Metabolic Research; 

93.848, Digestive Diseases and Nutrition 

Research; 93.849, Kidney Diseases, Urology 

and Hematology Research, National Institutes 

of Health, HHS) 

Dated: March 26, 2012. 

Jennifer S. Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2012–7833 Filed 3–30–12; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Eunice Kennedy Shriver National 

Institute of Child Health & Human 

Development; Notice of Closed 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The cooperative agreement 

applications and the discussions could 

disclose confidential trade secrets or 

commercial property such as patentable 

material, and personal information 

concerning individuals associated with 

the cooperative agreement applications, 

the disclosure of which would 

constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Child Health and Human Development 

Special Emphasis Panel, ZHD1 DSG–H 53 1. 

Date: April 16–17, 2012. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate 

cooperative agreement applications. 

Place: Doubletree Hotel Bethesda 

(Formerly Holiday Inn Select), 8120 

Wisconsin Avenue, Bethesda, MD 20814. 

Contact Person: David H. Weinberg, Ph.D., 

Scientific Review Officer, Division of 

Scientific Review, Eunice Kennedy Shriver 

National Institute of Child Health and 

Human Development, NIH, 6100 Executive 

Blvd., Room 5b01, Rockville, MD 20852, 

301–435–6973, David.Weinberg@nih.gov 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.864, Population Research; 

93.865, Research for Mothers and Children; 

93.929, Center for Medical Rehabilitation 

Research; 93.209, Contraception and 

Infertility Loan Repayment Program, National 

Institutes of Health, HHS) 

Dated: March 26, 2012. 

Jennifer S. Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2012–7830 Filed 3–30–12; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Allergy and 

Infectious Diseases; Notice of Meeting 

Pursuant to section 10(a) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of a meeting of the AIDS 

Research Advisory Committee, NIAID. 

The meeting will be open to the 

public, with attendance limited to space 

available. Individuals who plan to 

attend and need special assistance, such 

as sign language interpretation or other 

reasonable accommodations, should 

notify the Contact Person listed below 

in advance of the meeting. 

Name of Committee: AIDS Research 

Advisory Committee, NIAID, AIDS Vaccine 

Research Subcommittee. 

Date: May 15–16, 2012. 

Time: 8:30 a.m. to 5 p.m. 

Agenda: To update the Subcommittee on 

the use of the nonhuman primate model for 

AIDS vaccine research and to summarize and 

discuss plans for the two recently awarded 

Consortia for AIDS Vaccine Research in 

Nonhuman Primates. 

Place: National Institutes of Health, 5635 

Fishers Lane, Conference Rooms 508–510, 

Bethesda, MD 20892. 

Contact Person: James A. Bradac, Ph.D., 

Program Official, Preclinical Research and 

Development Branch, Division of AIDS, 

mstockstill on DSK4VPTVN1PROD with NOTICES

19678 Federal Register / Vol. 77, No. 63 / Monday, April 2, 2012 / Notices 

Room 5116, National Institutes of Health/ 

NIAID, 6700B Rockledge Drive, Bethesda, 

MD 20892–7628, 301–435–3754, 

jbradac@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.855, Allergy, Immunology, 

and Transplantation Research; 93.856, 

Microbiology and Infectious Diseases 

Research, National Institutes of Health, HHS) 

Dated: March 26, 2012. 

Jennifer S. Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2012–7828 Filed 3–30–12; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of General Medical 

Sciences; Notice of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

General Medical Sciences Special Emphasis 

Panel; NIH Loan Repayment Program for 

Clinical and Pediatric Research. 

Date: April 27, 2012. 

Time: 1 p.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Natcher Building, 45 Center Drive Room 

3An18B, Bethesda, MD 20892, (Telephone 

Conference Call). 

Contact Person: Margaret J. Weidman, 

Ph.D., Scientific Review Officer, Office of 

Scientific Review, National Institute of 

General Medical Sciences, National Institutes 

of Health, 45 Center Drive Room 3An18B, 

Bethesda, MD 20892, 301–594–3663, 

weidmanma@nigms.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.375, Minority Biomedical 

Research Support; 93.821, Cell Biology and 

Biophysics Research; 93.859, Pharmacology, 

Physiology, and Biological Chemistry 

Research; 93.862, Genetics and 

Developmental Biology Research; 93.88, 

Minority Access to Research Careers; 93.96, 

Special Minority Initiatives, National 

Institutes of Health, HHS) 

Dated: March 27, 2012. 

Jennifer S. Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2012–7825 Filed 3–30–12; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meeting. 

The meeting will be closed to the public 

in accordance with the provisions set forth in 

sections 552b(c)(4) and 552b(c)(6), Title 5 

U.S.C., as amended. The grant applications 

and the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, and 

personal information concerning individuals 

associated with the grant applications, the 

disclosure of which would constitute a 

clearly unwarranted invasion of personal 

privacy. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Member 

Conflict: Neurodegeneration. 

Date: April 11, 2012. 

Time: 10 a.m. to 1 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892, 

(Telephone Conference Call). 

Contact Person: Mary Custer, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4148, 

MSC 7850, Bethesda, MD 20892, (301) 435– 

1164, custerm@csr.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: March 27, 2012. 

Jennifer S. Spaeth, 

Director, Office of Federal Advisory 

Committee Policy 

[FR Doc. 2012–7823 Filed 3–30–12; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HOMELAND 

SECURITY 

Coast Guard 

[Docket No. USCG–2012–0220] 

Cooperative Research and 

Development Agreement: Asset 

Tracking and Reporting Technology 

AGENCY: Coast Guard, DHS. 

ACTION: Notice of intent; request for 

public comments. 

SUMMARY: The Coast Guard is 

announcing its intent to enter into a 

Cooperative Research and Development 

Agreement (CRADA) with General 

Dynamics C4 Systems, Inc. (General 

Dynamics), to test, evaluate, and 

document the strengths and weaknesses 

of at least one technical approach for 

exchanging asset position, status, and 

brief collaborative messages between the 

Coast Guard Incident Command Staff 

(ICS), deployed Coast Guard and nonCoast Guard personnel, and other 

mobile assets which are engaged within 

an ICS managed, Incident of National 

Significance Response. While the Coast 

Guard is currently considering 

partnering with General Dynamics, we 

are soliciting public comment on the 

nature of and participation of other 

parties in the proposed CRADA. In 

addition, the Coast Guard also invites 

other potential participants to submit 

proposals for consideration in similar 

CRADAs. 

DATES: Comments and related material 

on the proposed CRADA must either be 

submitted to our online docket via 

http://www.regulations.gov on or before 

May 2, 2012, or reach the Docket 

Management Facility by that date. 

Notifications from parties interested in 

participating as a non-Federal 

participant in a CRADA similar to the 

one described in this notice must reach 

the Docket Management Facility on or 

before May 2, 2012. 

ADDRESSES: You may submit written 

comments on this notice identified by 

docket number USCG–2012–0220 using 

any one of the following methods: 

(1) Federal eRulemaking Portal: 

http://www.regulations.gov. 

(2) Fax: 202–493–2251. 

(3) Mail: Docket Management Facility 

(M–30), U.S. Department of 

Transportation, West Building Ground 

Floor, Room W12–140, 1200 New Jersey 

Avenue SE., Washington, DC 20590– 

0001. 

(4) Hand delivery: Same as mail 

address above, between 9 a.m. and 

5 p.m., Monday through Friday, except 

Federal holidays. The telephone number 

is 202–366–9329. 

mstockstill on DSK4VPTVN1PROD with NOTICES